These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Biotech financing retrenches in Q2. Lawrence S Nat Biotechnol; 2006 Aug; 24(8):883. PubMed ID: 16900116 [No Abstract] [Full Text] [Related]
14. Public markets show signs of life. Mitchell P Nat Biotechnol; 2003 Aug; 21(8):833-4. PubMed ID: 12894181 [No Abstract] [Full Text] [Related]
15. My worst biotech investment. Jacobs T Nat Biotechnol; 2006 Apr; 24(4):401. PubMed ID: 16601718 [No Abstract] [Full Text] [Related]
16. Convincing a venture capitalist to invest in your idea. Dooley JF; Dooley JF Nat Biotechnol; 2003 Jul; 21 Suppl():BE45-8. PubMed ID: 12874980 [No Abstract] [Full Text] [Related]
17. The rise of European venture capital for biotechnology. Howell M; Trull M; Dibner MD Nat Biotechnol; 2003 Nov; 21(11):1287-91. PubMed ID: 14595356 [No Abstract] [Full Text] [Related]
18. Filters for preparing to meet a venture capitalist. Christoffersen R Nat Biotechnol; 2003 Jul; 21 Suppl():BE49-50. PubMed ID: 12874981 [No Abstract] [Full Text] [Related]
20. Looking at US versus European exit opportunities. Lawrence S Nat Biotechnol; 2005 Oct; 23(10):1203. PubMed ID: 16302294 [No Abstract] [Full Text] [Related] [Next] [New Search]